These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12228010)

  • 41. Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A.
    Walsh DS; Gettayacamin M; Leitner WW; Lyon JA; Stewart VA; Marit G; Pichyangkul S; Gosi P; Tongtawe P; Kester KE; Holland CA; Kolodny N; Cohen J; Voss G; Ballou WR; Heppner DG
    Vaccine; 2006 May; 24(19):4167-78. PubMed ID: 16574282
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery.
    Bråve A; Ljungberg K; Boberg A; Rollman E; Isaguliants M; Lundgren B; Blomberg P; Hinkula J; Wahren B
    Mol Ther; 2005 Dec; 12(6):1197-205. PubMed ID: 16112909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial.
    Kibuuka H; Berkowitz NM; Millard M; Enama ME; Tindikahwa A; Sekiziyivu AB; Costner P; Sitar S; Glover D; Hu Z; Joshi G; Stanley D; Kunchai M; Eller LA; Bailer RT; Koup RA; Nabel GJ; Mascola JR; Sullivan NJ; Graham BS; Roederer M; Michael NL; Robb ML; Ledgerwood JE;
    Lancet; 2015 Apr; 385(9977):1545-54. PubMed ID: 25540891
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Phase I safety study of plasmid DNA immunization targeting carcinoembryonic antigen in colorectal cancer patients.
    Staff C; Mozaffari F; Haller BK; Wahren B; Liljefors M
    Vaccine; 2011 Sep; 29(39):6817-22. PubMed ID: 21195077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase 1 safety and immunogenicity trial of malaria vaccine RTS,S/AS02A in adults in a hyperendemic region of western Kenya.
    Stoute JA; Heppner DG; Mason CJ; Siangla J; Opollo MO; Kester KE; Vigneron L; Voss G; Walter MJ; Tornieporth N; Cohen JD; Ballou WR
    Am J Trop Med Hyg; 2006 Jul; 75(1):166-70. PubMed ID: 16837726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasmid DNA malaria vaccine: the potential for genomic integration after intramuscular injection.
    Martin T; Parker SE; Hedstrom R; Le T; Hoffman SL; Norman J; Hobart P; Lew D
    Hum Gene Ther; 1999 Mar; 10(5):759-68. PubMed ID: 10210143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Small animal jet injection technique results in enhanced immunogenicity of hantavirus DNA vaccines.
    Brocato RL; Kwilas SA; Josleyn MD; Long S; Zeng X; Perley CC; Principe LM; Somerville B; Cohen MV; Hooper JW
    Vaccine; 2021 Feb; 39(7):1101-1110. PubMed ID: 33483212
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Self-Assembly DNA Polyplex Vaccine inside Dissolving Microneedles for High-Potency Intradermal Vaccination.
    Liao JF; Lee JC; Lin CK; Wei KC; Chen PY; Yang HW
    Theranostics; 2017; 7(10):2593-2605. PubMed ID: 28819449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of acceptability and usability of new delivery prototype device for intradermal vaccination in healthy subjects.
    Van Mulder TJ; Verwulgen S; Beyers KC; Scheelen L; Elseviers MM; Van Damme P; Vankerckhoven V
    Hum Vaccin Immunother; 2014; 10(12):3746-53. PubMed ID: 25531808
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synergistic effect of formulated plasmid and needle-free injection for genetic vaccines.
    Anwer K; Earle KA; Shi M; Wang J; Mumper RJ; Proctor B; Jansa K; Ledebur HC; Davis S; Eaglstein W; Rolland AP
    Pharm Res; 1999 Jun; 16(6):889-95. PubMed ID: 10397610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic immunization by jet injection of targeted pDNA-coated nanoparticles.
    Mumper RJ; Cui Z
    Methods; 2003 Nov; 31(3):255-62. PubMed ID: 14511958
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stable Immune Response Induced by Intradermal DNA Vaccination by a Novel Needleless Pyro-Drive Jet Injector.
    Chang C; Sun J; Hayashi H; Suzuki A; Sakaguchi Y; Miyazaki H; Nishikawa T; Nakagami H; Yamashita K; Kaneda Y
    AAPS PharmSciTech; 2019 Dec; 21(1):19. PubMed ID: 31820256
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A DNA vaccine targeting VEE virus delivered by needle-free jet-injection protects macaques against aerosol challenge.
    Suschak JJ; Bixler SL; Badger CV; Spik KW; Kwilas SA; Rossi FD; Twenhafel N; Adams ML; Shoemaker CJ; Spiegel E; Hooper JW
    NPJ Vaccines; 2022 Apr; 7(1):46. PubMed ID: 35459271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical performance and safety of adapters for intradermal delivery with conventional and autodisable syringes.
    Tsals I; Jarrahian C; Snyder FE; Saganic L; Saxon E; Zehrung D; Zimmerman G; Papania M; Klaff L
    Vaccine; 2015 Sep; 33(37):4705-11. PubMed ID: 25964169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP
    Edupuganti S; C De Rosa S; Elizaga M; Lu Y; Han X; Huang Y; Swann E; Polakowski L; A Kalams S; Keefer M; Maenza J; C Wise M; Yan J; Morrow MP; Khan AS; Boyer JD; Humeau L; White S; Sardesai NY; Bagarazzi ML; Gilbert PB; Kublin JG; Corey L; Weiner DB; On Behalf Of The Hvtn Study Team ; The Niaid-Funded Hiv Vaccine Trials Network
    Vaccines (Basel); 2020 Dec; 8(4):. PubMed ID: 33297341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High frequency ultrasound to assess skin thickness in healthy adults.
    Van Mulder TJ; de Koeijer M; Theeten H; Willems D; Van Damme P; Demolder M; De Meyer G; Beyers KC; Vankerckhoven V
    Vaccine; 2017 Mar; 35(14):1810-1815. PubMed ID: 27496276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines.
    Hallengärd D; Bråve A; Isaguliants M; Blomberg P; Enger J; Stout R; King A; Wahren B
    Genet Vaccines Ther; 2012 Aug; 10(1):5. PubMed ID: 22873174
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel intradermal tattoo-based injection device enhances the immunogenicity of plasmid DNA vaccines.
    Gomez AM; Babuadze GG; Plourde-Campagna MA; Azizi H; Berger A; Kozak R; de La Vega MA; Xiii A; Naghibosadat M; Nepveu-Traversy ME; Ruel J; Kobinger GP
    NPJ Vaccines; 2022 Dec; 7(1):172. PubMed ID: 36543794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and long-term immunological effects of CryJ2-LAMP plasmid vaccine in Japanese red cedar atopic subjects: A phase I study.
    Su Y; Romeu-Bonilla E; Anagnostou A; Fitz-Patrick D; Hearl W; Heiland T
    Hum Vaccin Immunother; 2017 Dec; 13(12):2804-2813. PubMed ID: 28605294
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.